Problems and solutions in hospital-acquired bacteraemia

Journal of Hospital Infection

Volumn 46, Issue 2, 2000, Pages 89-95

  Correa, L ^a   Pittet, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bacteraemia; Cross infection; Hospital; Prevention; Surveillance

Indexed keywords

ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIUM CONTAMINATION; BLOOD CULTURE; CATHETER; CROSS INFECTION; DIAGNOSTIC PROCEDURE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; PRACTICE GUIDELINE; REVIEW;

EID: 0033765288     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2000.0803     Document Type: Review

References (61)

1. Nosocomial infection surveillance
2. The nationwide nosocomial infection rate: A new need for vital statistics
3. Nosocomial bacteremia: An epidemiologic overview
4. Hospital costs and mortality attributed to nosocomial bacteremias
5. Nosocomial bloodstream infections
6. Endemic bacteremia in Columbia, South Carolina
7. Nosocomial bloodstream infections: Secular trends in a statewide surveillance program in Virginia
8. Bacteremia in Charleston County, South Carolina
9. The prevalence of nosocomial and community-acquired infections in Australian hospitals
10. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System
11. A three-year study of positive blood cultures, with emphasis on prognosis
12. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
13. Analysis of 1186 episodes of Gram-negative bacteremia in non-university hospitals: The effects of antimicrobial therapy
14. Bacteriemies nosocomiales
15. Hospital-acquired candidemia. The attributable mortality and excess length of stay
16. Factors affecting mortality outcome and risk of developing nosocomial bloodstream infection
17. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients
18. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
19. Influence of blood culture results on antibiotic choice in the treatment of bacteraemia
20. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates
21. Temporal trends in septicemia in a community hospital
22. Current risk factors for nosocomial bloodstream infection in a tertiary health care center
23. Morbidity/mortality and economics of hospital-acquired blood stream infections: A controlled study
24. Unique epidemiology of nosocomial infections in a children's hospital
25. Infections acquired in a pediatric hospital
26. Through a glass darkly: Nosocomial pseudoepidemics and pseudobacteremia
27. Pseudobacteremia
28. Pseudobacteraemia
29. Rapid classification of positive blood cultures. Prospective validation of a multivariate algorithm
30. Evaluation of positive blood cultures. Guidelines for early identification from valid positive cultures
31. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay
32. Staphylococcus epidermidis: An increasing cause of infection in patients with granulocytopenia
33. Coagulase-negative staphycoccal bacteremia in patients receiving immunosuppressive therapy
34. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis
35. Emergence of coagulase negative staphylococci as major nosocomial bloodstream pathogens
36. Bacteremia due to Staphylococcus epidermidis: Microbiologic, epidemiologic, clinical, and prognostic features
37. Evaluation of coagulase-negative staphylococci in blood cultures. A prospective clinical and microbiological study
38. Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus
39. Hospital-acquired bloodstream infections with Staphylococcus epidermidis
40. Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients. A clinically uncertain judgement
41. Catheter-related bloodstream infections
42. IV-related infections
43. Diagnosis of central venous catheter-related sepsis
44. Diagnosis of catheter-related bacteraemia: A prospective comparison of the time to positivity of hub-blood versus peripheral blood cultures
45. Differential quantitation with a commercial blood culture tube for diagnosis of catheter-related infection
46. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal
47. Effectiveness of antibiotic-lock technique with teicoplanin in coagulase-negative staphylococci catheter-related sepsis during long-term parenteral nutrition
48. Guideline for prevention of intravascular device-related infections. Hospital infection control practices advisory committee
49. A comparison of two antimicrobial-impregnated central venous catheters
50. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection
51. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care
52. Bloodstream infections: Epidemiology, pathophysiology and therapeutic perspectives
53. Quality standard for the treatment of bacteremia
54. Long-term survival following bacteremia or fungemia
55. Bloodstream infections in the elderly
56. Improved mortality in Gram-negative bacillary bacteremia
57. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom
58. The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study
59. Sepsis syndrome: A valid clinical entity. Methylprednisolone Severe Sepsis Study Group
60. Epidemiology of sepsis syndrome in 8 academic medical centers
61. Nosocomial infections in medical intensive care units in the United States